Atlas Trials

Application of SERS Technology in Clinical Diagnosis and Prognosis of Lung Cancer Immunotherapy

Clinical trial NCT05885815 · UNKNOWN

Trial details

NCT number
NCT05885815
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Cancer
Start date
2023-06-01
Primary completion
2024-06-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.